181 related articles for article (PubMed ID: 30536880)
1. Diacylglycerol kinase α-selective inhibitors induce apoptosis and reduce viability of melanoma and several other cancer cell lines.
Yamaki A; Akiyama R; Murakami C; Takao S; Murakami Y; Mizuno S; Takahashi D; Kado S; Taketomi A; Shirai Y; Goto K; Sakane F
J Cell Biochem; 2019 Jun; 120(6):10043-10056. PubMed ID: 30536880
[TBL] [Abstract][Full Text] [Related]
2. A novel diacylglycerol kinase α-selective inhibitor, CU-3, induces cancer cell apoptosis and enhances immune response.
Liu K; Kunii N; Sakuma M; Yamaki A; Mizuno S; Sato M; Sakai H; Kado S; Kumagai K; Kojima H; Okabe T; Nagano T; Shirai Y; Sakane F
J Lipid Res; 2016 Mar; 57(3):368-79. PubMed ID: 26768655
[TBL] [Abstract][Full Text] [Related]
3. Where do substrates of diacylglycerol kinases come from? Diacylglycerol kinases utilize diacylglycerol species supplied from phosphatidylinositol turnover-independent pathways.
Sakane F; Mizuno S; Takahashi D; Sakai H
Adv Biol Regul; 2018 Jan; 67():101-108. PubMed ID: 28918129
[TBL] [Abstract][Full Text] [Related]
4. Palmitic acid- and/or palmitoleic acid-containing phosphatidic acids are generated by diacylglycerol kinase α in starved Jurkat T cells.
Murakami Y; Murakami C; Hoshino F; Lu Q; Akiyama R; Yamaki A; Takahashi D; Sakane F
Biochem Biophys Res Commun; 2020 May; 525(4):1054-1060. PubMed ID: 32184022
[TBL] [Abstract][Full Text] [Related]
5. Combined inhibition/silencing of diacylglycerol kinase α and ζ simultaneously and synergistically enhances interleukin-2 production in T cells and induces cell death of melanoma cells.
Takao S; Akiyama R; Sakane F
J Cell Biochem; 2021 May; 122(5):494-506. PubMed ID: 33399248
[TBL] [Abstract][Full Text] [Related]
6. Identification of ritanserin analogs that display DGK isoform specificity.
Granade ME; Manigat LC; Lemke MC; Purow BW; Harris TE
Biochem Pharmacol; 2022 Mar; 197():114908. PubMed ID: 34999054
[TBL] [Abstract][Full Text] [Related]
7. Molecular Pathways: Targeting Diacylglycerol Kinase Alpha in Cancer.
Purow B
Clin Cancer Res; 2015 Nov; 21(22):5008-12. PubMed ID: 26420856
[TBL] [Abstract][Full Text] [Related]
8. Diacylglycerol kinase alpha suppresses tumor necrosis factor-alpha-induced apoptosis of human melanoma cells through NF-kappaB activation.
Yanagisawa K; Yasuda S; Kai M; Imai S; Yamada K; Yamashita T; Jimbow K; Kanoh H; Sakane F
Biochim Biophys Acta; 2007 Apr; 1771(4):462-74. PubMed ID: 17276726
[TBL] [Abstract][Full Text] [Related]
9. New Era of Diacylglycerol Kinase, Phosphatidic Acid and Phosphatidic Acid-Binding Protein.
Sakane F; Hoshino F; Murakami C
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947951
[TBL] [Abstract][Full Text] [Related]
10. The Roles of Diacylglycerol Kinase α in Cancer Cell Proliferation and Apoptosis.
Sakane F; Hoshino F; Ebina M; Sakai H; Takahashi D
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680338
[TBL] [Abstract][Full Text] [Related]
11. Dual activities of ritanserin and R59022 as DGKα inhibitors and serotonin receptor antagonists.
Boroda S; Niccum M; Raje V; Purow BW; Harris TE
Biochem Pharmacol; 2017 Jan; 123():29-39. PubMed ID: 27974147
[TBL] [Abstract][Full Text] [Related]
12. Screening of subtype-specific activators and inhibitors for diacylglycerol kinase.
Hayashi D; Tsumagari R; Liu K; Ueda S; Yamanoue M; Sakane F; Shirai Y
J Biochem; 2019 Jun; 165(6):517-522. PubMed ID: 30715374
[TBL] [Abstract][Full Text] [Related]
13. Diacylglycerol kinase inhibitor R59022-induced autophagy and apoptosis in the neuronal cell line NG108-15.
Takita T; Konuma T; Hanazato M; Inoue H
Arch Biochem Biophys; 2011 May; 509(2):197-201. PubMed ID: 21338572
[TBL] [Abstract][Full Text] [Related]
14. Epitope Mapping of Antidiacylglycerol Kinase α Monoclonal Antibody DaMab-2.
Sano M; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2019 Feb; 38(1):8-11. PubMed ID: 30648914
[TBL] [Abstract][Full Text] [Related]
15. Fatty acids inhibit growth-factor-induced diacylglycerol kinase alpha activation in vascular smooth-muscle cells.
Du X; Jiang Y; Qian W; Lu X; Walsh JP
Biochem J; 2001 Jul; 357(Pt 1):275-82. PubMed ID: 11415460
[TBL] [Abstract][Full Text] [Related]
16. Diacylglycerol kinase alpha activity promotes survival of CD4+ 8+ double positive cells during thymocyte development.
Outram SV; Crompton T; Merida I; Varas A; Martinez-A C
Immunology; 2002 Apr; 105(4):391-8. PubMed ID: 11985659
[TBL] [Abstract][Full Text] [Related]
17. Not expecting the unexpected: diacylglycerol kinase alpha as a cancer target.
Bhat KP; Aldape K
Cancer Discov; 2013 Jul; 3(7):726-7. PubMed ID: 23847350
[TBL] [Abstract][Full Text] [Related]
18. Diacylglycerol kinase alpha enhances hepatocellular carcinoma progression by activation of Ras-Raf-MEK-ERK pathway.
Takeishi K; Taketomi A; Shirabe K; Toshima T; Motomura T; Ikegami T; Yoshizumi T; Sakane F; Maehara Y
J Hepatol; 2012 Jul; 57(1):77-83. PubMed ID: 22425622
[TBL] [Abstract][Full Text] [Related]
19. Diacylglycerol kinase α is a critical signaling node and novel therapeutic target in glioblastoma and other cancers.
Dominguez CL; Floyd DH; Xiao A; Mullins GR; Kefas BA; Xin W; Yacur MN; Abounader R; Lee JK; Wilson GM; Harris TE; Purow BW
Cancer Discov; 2013 Jul; 3(7):782-97. PubMed ID: 23558954
[TBL] [Abstract][Full Text] [Related]
20. Establishment and Epitope Mapping of Anti-Diacylglycerol Kinase α Monoclonal Antibody DaMab-8 for Immunohistochemical Analyses.
Sano M; Kaneko MK; Suzuki H; Kato Y
Monoclon Antib Immunodiagn Immunother; 2020 Feb; 39(1):1-5. PubMed ID: 31099705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
